PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Aztreonam - Bacterial infection
PAD Profile : Aztreonam - Bacterial infection
Keywords :
antibiotic, antibacterial, beta-lactam
Brand Names Include :
Azactam
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Injection
Important Information :
Restricted Use - for use when indicated by NICE guidelines, local trust antimicrobial guidelines or specialist microbiology recommendation
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Co-amoxiclav
- Cefaclor
- Clindamycin
- Fusidic acid
- Amoxicillin
- Azithromycin
- Benzylpenicillin sodium (Penicillin G)
- Cefalexin
- Cefotaxime sodium
- Ceftriaxone sodium
- Ciprofloxacin
- Clarithromycin
- Co-trimoxazole (Trimethoprim/sulfamethoxazole)
- Doxycycline hyclate
- Erythromycin
- Flucloxacillin sodium
- Fosfomycin
- Levofloxacin
- Metronidazole
- Nitrofurantoin
- Doxycycline
- Phenoxymethylpenicillin (Penicillin V)
- Trimethoprim
- Thalidomide
- Amikacin
- Cefepime
- Cefiderocol
- Cefixime
- Ceftazidime pentahydrate
- Cetftolozone with tazobactam
- Cefuroxime sodium
- Chloramphenicol
- Dalbavancin hydrochloride
- Dapsone
- Daptomycin
- Ceftazidime with avibactam
- Demeclocycline hydrochloride
- Ertapenem sodium
- Gentamicin sulfate
- Imipenem with cilastatin
- Meropenem
- Moxifloxacin
- Norfloxacin
- Ofloxacin
- Piperacillin sodium/tazobactam sodium
- Rifabutin
- Sodium fusidate
- Streptomycin
- Sulfadiazine
- Teicoplanin
- Temocillin sodium
- Tigecycline
- Tinidazole
- Vancomycin hydrochloride
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
05. Infections
05.01.02. Cephalosporins and other beta-lactams